Rheumatoid arthritis increases the risk of nontuberculosis mycobacterial disease and active pulmonary tuberculosis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Yeh, Jun Jun ^a,b,c   Wang, Yu Chiao ^d,e   Sung, Fung Chang ^e   Kao, Chia Hung ^d,e  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; GENDER; HAZARD RATIO; HUMAN; INCIDENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; POPULATION RESEARCH; PREVALENCE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; TAIWAN; ARTHRITIS, RHEUMATOID; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; TUBERCULOSIS, PULMONARY;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84908453613     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110922     Document Type: Article

References (43)

1. Mutru O, Laakso M, Isomaki H, Koota K (1985) Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) 290:1797-1799.
2. Crowson CS, Hoganson DD, Fitz-Gibbon PD, Matteson EL (2012) Development and validation of a risk score for serious infection in patients with rheumatoid arthritis. Arthritis Rheum 64:2847-2855.
3. Listing J, Gerhold K, Zink A (2013) The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford) 52:53-61.
4. Hsia EC, Cush JJ, Matteson EL, Beutler A, Doyle MK, et al. (2013) Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials. Arthritis Care Res (Hoboken) 65:309-313.
5. Takabayashi K, Hanaoka H (2004) [Collagen diseases with opportunistic infections]. Nihon Rinsho Meneki Gakkai Kaishi 27:156-163.
6. Park JS, Jung ES, Choi W, Park SY, Rim MY, et al. (2013) Mycobacterium intracellulare Pulmonary Disease with Endobronchial Caseation in a Patient Treated with Methotrexate. Tuberc Respir Dis (Seoul) 75:28-31.
7. Collins CS, Terrell C, Mueller P (2013) Disseminated Mycobacterium haemophilum infection in a 72-year-old patient with rheumatoid arthritis on infliximab. BMJ Case Rep 2013.
8. Yamakawa H, Takayanagi N, Miyahara Y, Ishiguro T, Kanauchi T, et al. (2013) Prognostic factors and radiographic outcomes of nontuberculous mycobacterial lung disease in rheumatoid arthritis. J Rheumatol 40:1307-1315.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383.
10. Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245-1251.
11. Hall SF (2006) A user's guide to selecting a comorbidity index for clinical research. J Clin Epidemiol 59:849-855.
12. Tiippana-Kinnunen T, Kautiainen H, Paimela L, Leirisalo-Repo M (2013) Comorbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up. Scand J Rheumatol.
13. Newton SM, Mackie SL, Martineau AR, Wilkinson KA, Kampmann B, et al. (2008) Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients. Clin Vaccine Immunol 15:506-512.
14. Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, et al. (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 34:706-711.
15. Wolfe F, Michaud K, Anderson J, Urbansky K (2004) Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 50:372-379.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324.
17. (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 156:S1-25.
18. WHO (1994) WHO tuberculosis programme-Framework for effective tuberculosis control. In. Geneva, Switzerland.
19. Yeh JJ, Neoh CA, Chen CR, Chou CY, Wu MT (2014) A high resolution computer tomography scoring system to predict culture-positive pulmonary tuberculosis in the emergency department. PLoS ONE 9:e93847.
20. Yeh JJ, Chen SC, Chen CR, Yeh TC, Lin HK, et al. (2014) A high-resolution computed tomography-based scoring system to differentiate the most infectious active pulmonary tuberculosis from community-acquired pneumonia in elderly and non-elderly patients. Eur Radiol.
21. Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, et al. (2013) Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis 72:37-42.
22. Menzies D, Nahid P (2013) Update in tuberculosis and nontuberculous mycobacterial disease 2012. Am J Respir Crit Care Med 188:923-927.
23. Perez-Guzman C, Vargas MH (2010) Mycobacterial infections in the elderly. Semin Respir Crit Care Med 31:575-586.
24. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, et al. (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367-416.
25. Swart RM, van Ingen J, van Soolingen D, Slingerland R, Hendriks WD, et al. (2009) Nontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists. Emerg Infect Dis 15:1700-1701.
26. Chan ED, Iseman MD (2010) Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease. Gend Med 7:5-18.
27. Seve P, Broussolle C, Pavic M (2013) [Primary immunodeficiencies presenting with autoimmune cytopenias in adults]. Rev Med Interne 34:148-153.
28. Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, et al. (2006) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117:883-896.
29. Sleasman JW (1996) The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res 10:57-61.
30. Wagner UG, Koetz K, Weyand CM, Goronzy JJ (1998) Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A 95:14447-14452.
31. Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, et al. (2010) The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J 36:1185-1206.
32. Harboe E, Damas JK, Omdal R, Froland SS, Sjursen H (2012) [Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis]. Tidsskr Nor Laegeforen 132:1867-1871.
33. Winthrop KL, Iseman M (2013) Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy. Nat Rev Rheumatol 9:524-531.
34. Petersson IF, Strombeck B, Andersen L, Cimmino M, Greiff R, et al. (2013) Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc-net project. Ann Rheum Dis.
35. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580-1588.
36. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, et al. (2010) Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 182:977-982.
37. Yeh JJ, Wang YC, Sung FC, Chou CY, Kao CH (2014) Nontuberculosis mycobacterium disease is a risk factor for chronic obstructive pulmonary disease: a nationwide cohort study. Lung 192:403-411.
38. Yeh JJ, Wang YC, Lin CL, Chou CY, Yeh TC, et al. (2014) Nontuberculous mycobacterial infection is associated with increased respiratory failure: a nationwide cohort study. PLoS ONE 9:e99260.
39. Erbes R, Oettel K, Raffenberg M, Mauch H, Schmidt-Ioanas M, et al. (2006) Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J 27:1223-1228.
40. Mori S, Tokuda H, Sakai F, Johkoh T, Mimori A, et al. (2012) Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan. Mod Rheumatol 22:727-737.
41. Lash TL, Fox MP, MacLehose RF, Maldonado G, McCandless LC, et al. (2014) Good practices for quantitative bias analysis. Int J Epidemiol.
42. Chen YY, Chang JR, Huang WF, Kuo SC, Yeh JJ, et al. (2014) Molecular epidemiology of Mycobacterium tuberculosis in aboriginal peoples of Taiwan, 2006-2011. J Infect 68:332-337.
43. Booth CM, Rapoport B (2011) Uptake of novel medical therapies in the general population. Curr Oncol 18:105-108.